Alan R. Meyer active positions
| Companies | Position | Start | End |
|---|---|---|---|
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Director/Board Member | 31/12/2017 | - |
| Founder | 31/12/2001 | - | |
| Chief Executive Officer | 31/12/2001 | 31/12/2017 |
Career history of Alan R. Meyer
Former positions of Alan R. Meyer
| Companies | Position | Start | End |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Director/Board Member | - | 06/06/2021 |
| Founder | 31/01/2018 | 06/06/2021 | |
| AKSYS LTD. | Director/Board Member | - | 22/06/2006 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Director/Board Member | 31/12/1991 | 31/12/1999 |
| Director of Finance/CFO | 31/12/1991 | 31/12/1999 |
Training of Alan R. Meyer
| University of Illinois | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Director/Board Member | 4 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| AKSYS LTD. | Finance |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
- Stock Market
- Insiders
- Alan R. Meyer
- Experience
